FDA panel backs highly controversial ALS drug in rare 2nd review
WASHINGTON (AP) — A panel of federal health advisers voted Wednesday to recommend approval of an experimental drug to treat Lou Gehrig’s disease, a remarkable turnaround for the highly controversial drug which was previously rejected by the same group earlier this year. Food and Drug Administration advisers voted 7 to 2 that Amylyx Pharma’s data … Read more